Document Type : Original Article


1 Ph.D, Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran

2 M.Sc, Liver and Digestive Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran


 Background and aims: Maternal primary and recurrent infection of cytomegalovirus (CMV) may be transmitted to the fetus during pregnancy and may have complications such as death or growth, along with the development retardation of the fetus and infant. The aim of this study was to determine the prevalence of immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies against CMV in young women, Sanandaj, Iran.
Methods: To this end, 90 women (15-40 years old) referring to a clinical laboratory were randomly selected and announced their informed consent to participate in this cross-sectional study. Demographic information and women’s data were collected, including pregnancy, history of abortion, and history of blood transfusion. Then, women’s sera were measured for CMV IgG and IgM antibodies using the electrochemiluminescence technique. Finally, the data were analyzed by SPSS statistical software.
Results: The prevalence of IgG and IgM antibodies against CMV in women was 92.2% (95% CI = 86.5-97.8) and 0%, respectively. In addition, the average CMV IgG antibody level was about 137.52 ± 85.215 SD IU/mL. The results revealed a significant statistical association between IgG antibody and pregnancy (P value = 0.012) while there was no association between CMV IgG antibody and other demographic data.
Conclusions: In general, high percentages of women had CMV IgG antibody whereas 7.8% of them were susceptible. They are expected to acquire CMV primary infection, and therefore, the screening of antibodies to CMV is suggested for prenatal care.


Main Subjects

1.van Rijckevorsel GG, Bovée LP, Damen M, Sonder GJ, Schim van der Loeff MF, van den Hoek A. Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care. BMC Public Health. 2012;12:475. doi: 10.1186/1471- 2458-12-475. 
2.Mellor AL, Munn DH. Extinguishing maternal immune responses during pregnancy: implications for immunosuppression. Semin Immunol. 2001;13(4):213-8. doi: 10.1006/smim.2000.0317. 
3.Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpää R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cytomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG. 2005;112(1):50-6. doi: 10.1111/j.1471-0528.2004.00320.x. 
4.Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26(1):86-102. doi: 10.1128/cmr.00062- 12. 
5.Karacan M, Batukan M, Cebi Z, Berberoglugil M, Levent S, Kir M, et al. Screening cytomegalovirus, rubella and toxoplasma infections in pregnant women with unknown pre-pregnancy serological status. Arch Gynecol Obstet. 2014;290(6):1115- 20. doi: 10.1007/s00404-014-3340-3. 
6.Wujcicka W, Gaj Z, Wilczynski J, Sobala W, Spiewak E, Nowakowska D. Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011. Eur J Clin Microbiol Infect Dis. 2014;33(11):1951-8. doi: 10.1007/ s10096-014-2170-3. 
7.Sharifi P, Khodabandehloo M, Rahimiyan-Zarif B. Seroprevalence of parvovirus B19 antibodies in young women, Sanandaj, Iran. Iran J Virol. 2013;7(4):1-6. doi: 10.21859/ isv.7.4.1. 
8.Yamaguchi K, Sawada T, Naraki T, Igata-Yi R, Shiraki H, Horii Y, et al. Detection of Borna disease virus-reactive antibodies from patients with psychiatric disorders and from horses by electrochemiluminescence immunoassay. Clin Diagn Lab Immunol. 1999;6(5):696-700. 
9.Guo W, Ding H, Gu C, Liu Y, Jiang X, Su B, et al. Potential-resolved multicolor Electrochemiluminescence for multiplex immunoassay in a single sample. J Am Chem Soc. 2018;140(46):15904-15. doi: 10.1021/jacs.8b09422. 
10.Yu H. Comparative studies of magnetic particle-based solid phase fluorogenic and electrochemiluminescent immunoassay. J Immunol Methods. 1998;218(1-2):1-8. doi: 10.1016/s0022-1759(98)00047-7. 
11.Taniguchi K, Watanabe N, Sato A, Jwa SC, Suzuki T, Yamanobe Y, et al. Changes in cytomegalovirus seroprevalence in pregnant Japanese women-a 10-year single center study. J Clin Virol. 2014;59(3):192-4. doi: 10.1016/j.jcv.2013.12.013. 
12.Pembrey L, Raynor P, Griffiths P, Chaytor S, Wright J, Hall AJ. Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study. PLoS One. 2013;8(11):e81881. doi: 10.1371/ journal.pone.0081881. 
13.N’Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, et al. Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France. PLoS One. 2014;9(2):e89857. doi: 10.1371/journal.pone.0089857. 
14.Sirin MC, Agus N, Yilmaz N, Bayram A, Derici YK, Samlioglu P, et al. Seroprevalence of Toxoplasma gondii, Rubella virus and cytomegalovirus among pregnant women and the importance of avidity assays. Saudi Med J. 2017;38(7):727-32. doi: 10.15537/smj.2017.7.18182. 
15.Aljumaili ZK, Alsamarai AM, Najem WS. Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq. J Infect Public Health. 2014;7(4):277-88. doi: 10.1016/j. jiph.2013.08.006. 
16.Kamel N, Metwally L, Gomaa N, Sayed Ahmed WA, Lotfi M, Younis S. Primary cytomegalovirus infection in pregnant Egyptian women confirmed by cytomegalovirus IgG avidity testing. Med Princ Pract. 2014;23(1):29-33. doi: 10.1159/000354758. 
17.Ali S, Khan FA, Mian AA, Afzal MS. Seroprevalence of cytomegalovirus, herpes simplex virus and rubella virus among pregnant women in KPK province of Pakistan. J Infect Dev Ctries. 2014;8(3):389-90. doi: 10.3855/jidc.3854. 
18.Al-Hindi A, Al-Helou T, Al-Helou Y. Seroprevalence of Toxoplasma gondii, cytomegalovirus, rubella virus and Chlamydia trachomatis among infertile women attending in vitro fertilization center, Gaza strip, Palestine. J Egypt Soc Parasitol. 2010;40(2):451-8. 
19.Erfanianahmadpoor M, Nasiri R, Vakili R, Hassannia T. Seroprevalence, transmission, and associated factors of specific antibodies against cytomegalovirus among pregnant women and their infants in a regional study. Saudi Med J. 2014;35(4):360-4. 
20.Barazesh A, Zandi K, Hadavand F, Moatamed N, Hefzollah F, Hefzollah B, et al. Seroepidemiology of rubella, cytomegalovirus, Herpes simplex & Varicella zoster virus in college women of Bushehr. Iran South Med J. 2014;16(6):459- 66. [Persian]. 
21.Mostafavi SN, Ataei B, Nokhodian Z, Yaran M, Babak A, Salehi A, et al. Seroprevalence of cytomegalovirus infection and estimate of congenital cytomegalovirus infection in Isfahan state, Iran: a population based study. Pak J Med Sci. 2013;29(1 Suppl):418-22. doi: 10.12669/pjms.291(Suppl).3546. 
22.Monavari SH, Keyvani H, Abedi Kiasari B, Mollaei H, Fazlalipour M, Salehi Vaziri M, et al. Detection of cytomegalovirus (CMV) antibodies or DNA sequences from ostensibly healthy Iranian mothers and their neonates. Int J Med Med Sci. 2012;4(8):155- 9. doi: 10.5897/ijmms11.138. 
23.Bagheri L, Mokhtarian H, Sarshar N, Ghahramani M. Seroepidemiology of cytomegalovirus infection during pregnancy in Gonabad, east of Iran: a cross-sectional study. J Res Health Sci. 2012;12(1):38-44. 
24.Sotoodeh jahromi A, Jamshidi Makiani M, Farjam M, Madani A, Amirian M, Eqbal Eftekhari T, et al. Cytomegalovirus immunity in pregnancy in south of Iran. Am J Infect Dis. 2010;6(1):8-12. doi: 10.3844/ajidsp.2010.8.12. 
25.Sabouri Ghannad M, Roshanaei G, Habibi H, Yousefi S. The assessment of affected factors on cytomegalovirus and rubella virus prevalence in females in Hamadan, Iran. Acta Med Iran. 2014;52(4):303-9. 
26.Zhang S, Hu L, Chen J, Xu B, Zhou YH, Hu Y. Cytomegalovirus seroprevalence in pregnant women and association with adverse pregnancy/neonatal outcomes in Jiangsu province, China. PLoS One. 2014;9(9):e107645. doi: 10.1371/journal. pone.0107645. 
27.Shi TL, Huang LJ, Xiong YQ, Zhong YY, Yang JJ, Fu T, et al. The risk of herpes simplex virus and human cytomegalovirus infection during pregnancy upon adverse pregnancy outcomes: a meta-analysis. J Clin Virol. 2018;104:48-55. doi: 10.1016/j. jcv.2018.04.016. 
28.Barbosa NG, Yamamoto AY, Duarte G, Aragon DC, Fowler KB, Boppana S, et al. Cytomegalovirus shedding in seropositive pregnant women from a high-seroprevalence population: the Brazilian cytomegalovirus hearing and maternal secondary infection study. Clin Infect Dis. 2018;67(5):743-50. doi: 10.1093/cid/ciy166. 
29.Wang C, Dollard SC, Amin MM, Bialek SR. Cytomegalovirus IgM seroprevalence among women of reproductive age in the United States. PLoS One. 2016;11(3):e0151996. doi: 10.1371/ journal.pone.0151996.